Amy Schumer Says Mounjaro Improved Perimenopause Symptoms and Libido

If there’s one thing Amy Schumer has never been accused of, it’s keeping quiet about what’s happening in her body. In spring 2025, she talked openly about being in perimenopause, using hormone therapy, and taking Mounjaro (tirzepatide)and she said the combo made a noticeable difference in how she felt, including more energy and a better sex drive.

That kind of headline can feel like a breath of fresh air (finally, someone says the “weird midlife stuff” out loud) and also a recipe for confusion (wait… is a diabetes drug now a perimenopause hack?). Let’s break down what she shared, what Mounjaro actually is, what perimenopause can do to libido, and what experts generally say about why someone might feel better when weight, hormones, sleep, and metabolism start moving in the right direction.

Quick note: This article is educational, not medical advice. Medications like Mounjaro are prescription-only and should be used only under care from a licensed clinician.

What Amy Schumer Said (and Why It Resonated)

Schumer described classic “something is off” midlife symptomsthen said she started hormone therapy (typically estrogen with progesterone for people who still have a uterus) and also used Mounjaro. In her telling, the changes weren’t subtle: she reported feeling like her perimenopause symptoms eased significantly, and she also mentioned an uptick in libido.

The reason that landed with so many people is simple: perimenopause is common, but it often feels invisible. Lots of women describe a frustrating mix of fatigue, sleep changes, mood shifts, weight changes, and a sex drive that suddenly seems to have wandered off without leaving a forwarding address. When a celebrity says, “Hey, this is happeningand I did something about it,” it can help normalize the conversation.

But normalizing the conversation shouldn’t mean oversimplifying the science. Schumer’s experience is one person’s reportnot a clinical trialand it’s also a “stack” of interventions (hormones + a metabolic medication + likely other lifestyle/health changes). That matters when you try to understand what helped and why.

Perimenopause 101: Why Symptoms (and Libido) Can Shift

Perimenopause is the transition phase before menopause, when hormone levels fluctuate and menstrual cycles change. It can last for years. Some people breeze through it; others feel like their body updated its operating system overnightwith no patch notes.

Common perimenopause symptoms

• Hot flashes and night sweats
• Sleep disruption (sometimes even without hot flashes)
• Mood changes (irritability, anxiety, low mood)
• Brain fog or trouble concentrating
• Vaginal dryness or discomfort
• Changes in sexual desire
• Weight and body-composition changes

Why libido can dip (or change)

Libido isn’t one leverit’s more like a mixing board. Hormonal shifts can affect desire and physical comfort, but so can sleep deprivation, stress, relationship dynamics, body image, pain, medications, and mental health. And if sex becomes uncomfortable because of dryness or irritation, desire often dropsnot because you “lost your spark,” but because your brain is doing basic protective math.

Translation: in perimenopause, libido changes are commonand they’re usually multi-factor, not a single-cause mystery.

What Is Mounjaro, Exactly?

Mounjaro is the brand name for tirzepatide, a once-weekly injectable medication approved in the U.S. to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. It works on two hormone pathways involved in appetite and blood sugar regulation: GLP-1 and GIP.

You may also hear about Zepbound, which is tirzepatide marketed for chronic weight management in adults with obesity (or overweight with weight-related conditions). Same active ingredient, different FDA-approved indication and labeling.

What tirzepatide tends to do in studies

In large clinical trials, tirzepatide has been associated with substantial weight loss for many participants and meaningful metabolic improvements. That doesn’t mean it’s “easy mode”side effects and access/coverage issues are realbut it helps explain why the medication is central to current conversations about obesity and metabolic health.

So… Could Mounjaro Improve Perimenopause Symptoms and Libido?

Here’s the careful answer: tirzepatide is not an FDA-approved treatment for perimenopause symptoms or sexual desire. But it could indirectly improve how someone feels in midlife by affecting factors that overlap with perimenopause complaintsespecially energy, sleep, inflammation, and self-perceived wellbeing.

1) Better sleep can change everything

Perimenopause often disrupts sleep. Separately, higher body weight is associated with sleep issues like obstructive sleep apnea. If someone loses weight and sleeps better, daytime energy and mood can improveand libido can follow. It’s not magic; it’s biology (plus the fact that nobody feels flirty when they’re exhausted).

2) Stable blood sugar and fewer energy crashes

For people with insulin resistance or type 2 diabetes, improved glycemic control can mean fewer roller-coaster days. Feeling steadier can translate into “I can handle my life again,” which is an underrated ingredient for desire.

3) Less physical discomfort

If weight loss reduces joint pain, reflux, or general inflammation, the body can feel more comfortablemaking intimacy more appealing. Desire is often easier when your body isn’t negotiating with you like a hostile union.

4) Confidence and mental load

This is tricky to talk about without turning it into “thin equals happy,” because that’s not trueand it’s not a healthy message. But some people report that improvements in health markers, mobility, or stamina reduce daily stress, and that can improve mood and sexual interest. The key is focusing on function and wellbeing, not chasing an aesthetic ideal.

Where hormone therapy fits in

Schumer also described using hormone therapy. That matters because hormone therapy is a well-established treatment for bothersome vasomotor symptoms (like hot flashes) and for genitourinary symptoms (like vaginal dryness) that can affect comfort and sexual function. If hormone therapy reduces symptoms and improves sleep, it can also improve quality of lifewhich can spill over into libido.

In other words, it may not be “Mounjaro did everything.” It may be: hormones addressed hormone-driven symptoms, while metabolic treatment improved weight- and insulin-related factors, and together that made her feel more like herself.

Important Safety Reality Check (Because Your Body Deserves the Fine Print)

Tirzepatide medications can have side effectsoften gastrointestinaland they aren’t appropriate for everyone. Labels include serious warnings (including a boxed warning related to thyroid C-cell tumors observed in rats and contraindications for people with certain thyroid cancer histories). Other risks include pancreatitis, gallbladder issues, dehydration from vomiting/diarrhea, and low blood sugar when combined with certain diabetes medications.

None of that is meant to scare people; it’s meant to keep the conversation honest. If you see a celebrity doing well on a medication, remember: you’re seeing the highlight reel, not the screening checklist.

If You’re in Perimenopause and Feeling “Not Like Yourself,” Here’s a Smarter Framework

Perimenopause symptoms are realand treatablebut the best approach usually starts with clarity, not trends.

Consider tracking patterns for a few weeks

• Sleep quality (not just hours)
• Hot flashes/night sweats
• Mood and anxiety
• Cycle changes
• Sexual comfort and desire (separatelycomfort and desire aren’t the same)
• Energy levels and appetite changes

Bring targeted questions to a clinician

• “Could this be perimenopause, and what signs support that?”
• “Would hormone therapy be appropriate for my symptoms and health history?”
• “Are sleep issues driving my fatigue and low desire?”
• “Do I have insulin resistance, thyroid issues, anemia, or other conditions that mimic ‘perimenopause fog’?”
• “If weight is affecting my health, what evidence-based options exist (nutrition, movement, sleep, medications)?”

That kind of conversation keeps you in the driver’s seat, even when your hormones are trying to grab the wheel.

Real-World Experiences (Extra): What People Commonly Report When Perimenopause, HRT, and GLP-1 Meds Overlap

Schumer’s story sparked interest because it connects two big, very real midlife themes: (1) perimenopause can feel like a chaotic “symptom bundle,” and (2) metabolic medications can change appetite and weight in ways that ripple into daily life. While everyone’s experience is different, clinicians and studies often describe a handful of patterns that show up again and again.

Experience pattern #1: “My brain got quieter about foodand my energy shifted”

Many people on GLP-1–based medications describe reduced appetite and fewer cravings. For some, that comes with a surprising mental benefit: less constant planning, debating, and second-guessing around food. When that mental load drops, people sometimes use that freed-up bandwidth for sleep routines, stress reduction, or consistent mealshabits that can improve energy during perimenopause.

The fine print: early weeks can be bumpy. Nausea, constipation, diarrhea, or stomach discomfort are common side effects listed in medication guides. Some people say they feel amazing metabolically but have to troubleshoot the GI learning curve with their clinician’s help.

Experience pattern #2: “My sleep improved, and then… everything improved”

Sleep is the ultimate domino. When perimenopause disrupts sleep, mood and libido often suffer. When sleep improveswhether from fewer night sweats, better routines, or changes in weight-related sleep issuespeople often report feeling more patient, more emotionally steady, and more interested in intimacy.

This is one reason Schumer’s story makes intuitive sense: if hormone therapy reduces hot flashes and tirzepatide supports meaningful weight or metabolic changes, the combined effect could make sleep and daytime functioning feel dramatically better.

Experience pattern #3: “My desire wasn’t ‘broken’my comfort was”

A lot of midlife sexual frustration is really a comfort problem in disguise. Lower estrogen can contribute to dryness, irritation, and pain with sex, and that can train the brain to associate intimacy with discomfort. When hormone therapy (especially local/vaginal estrogen when appropriate) improves tissue comfort, some people find desire returnsnot because they forced it, but because their body stopped bracing for impact.

Importantly, a metabolic medication does not directly treat vaginal dryness. If someone’s libido improved while using tirzepatide, it may be because they felt more energetic or confident, or because other symptoms (sleep, mood, pain, comfort) improved at the same time.

Experience pattern #4: “I had to separate ‘weight loss’ from ‘wellness’”

Some people report a psychological tug-of-war: feeling better physically, but also feeling pressureinternal or externalto make weight loss the headline. The healthier framing is outcomes that matter: blood sugar, mobility, stamina, sleep quality, and mental health. Libido tends to respond to that broader “I feel okay in my body” shift more than to a number on a scale.

Experience pattern #5: “The best results came from personalization, not copying a celebrity”

This might be the most practical takeaway. What worked for Schumer involved medical care tailored to her body and symptoms. For someone else, the best plan might be hormone therapy alone, nonhormonal symptom treatments, pelvic care for dryness, therapy for stress and relationship strain, sleep evaluation, or addressing conditions that mimic perimenopause fatigue.

The goal isn’t to recreate someone else’s regimen. The goal is to treat your drivershormonal, metabolic, emotional, relational, and physicalso you can feel like yourself again (or, honestly, a version of yourself who sleeps through the night).

Conclusion: A Celebrity Story, a Real Conversation, and a Useful Reminder

Amy Schumer’s comments put a spotlight on something many people feel but don’t always say out loud: perimenopause can affect energy, mood, and libidoand improvement is possible. Mounjaro isn’t a perimenopause medication, but metabolic health can influence the same day-to-day quality-of-life factors that shape symptoms and sexual desire. And when hormone therapy is appropriate, it can meaningfully reduce classic perimenopause complaints.

The smartest takeaway is not “everyone should do what she did.” It’s: if you’re struggling, you’re not aloneand there are evidence-based options worth discussing with a clinician.